Zelapar Interactions
There are 512 drugs known to interact with Zelapar (selegiline), along with 11 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 129 are major, 381 are moderate, and 2 are minor.
- View all 512 medications that may interact with Zelapar
- View Zelapar alcohol/food interactions (3)
- View Zelapar disease interactions (11)
Most frequently checked interactions
View interaction reports for Zelapar (selegiline) and the medicines listed below.
- acetaminophen
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Afinitor Disperz (everolimus)
- amantadine
- amlodipine
- amoxicillin
- Arava (leflunomide)
- Austedo (deutetrabenazine)
- Bosulif (bosutinib)
- Calcium 600 D (calcium / vitamin d)
- Cathflo Activase (alteplase)
- Cayston (aztreonam)
- Celebrex (celecoxib)
- Cerezyme (imiglucerase)
- Cialis (tadalafil)
- clonidine
- Copaxone (glatiramer)
- Corlanor (ivabradine)
- Cosmegen (dactinomycin)
- Cymbalta (duloxetine)
- Inderal (propranolol)
- Januvia (sitagliptin)
- Kynamro (mipomersen)
- Lyrica (pregabalin)
- Mirapex (pramipexole)
- Sirturo (bedaquiline)
- Stalevo (carbidopa / entacapone / levodopa)
- Symbicort (budesonide / formoterol)
Zelapar alcohol/food interactions
There are 3 alcohol/food interactions with Zelapar (selegiline).
Zelapar disease interactions
There are 11 disease interactions with Zelapar (selegiline) which include:
- hypotension
- major psychotic disorders
- severe renal dysfunction
- hypotension
- cardiac disease
- glaucoma
- hypertension
- liver disease
- melanoma
- sleep disorders
- urinary retention
More about Zelapar (selegiline)
- Zelapar consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.